Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baker Bros. Buy Some Shares of Mirati Therapeutics

Baker Bros., Mirati Therapeutics: In a new form 4 from today, Julian and Felix Baker‘s Baker Bros. Advisors reported buying 400,000 shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX). Following the transaction, Baker Bros own an aggregate amount of some 2.4 million shares. The shares have been purchased in terms of an underwritten public offering of Mirati Therapeutics, the per-share price amounting to $17.5 apiece.

Mirati Therapeutics, Inc

Disclosure: none

Recommended Reading:

The 10 Main Hedge Fund Moves of the Past Seven Days

Weiss Asset Management Lowers Its Position in LSE-listed Tamar

Outerwall Listens to Jana — Should You?

Loading...